Owens & Minor narrowed its full-year guidance, notched a $310 goodwill impairment and said it plans to raise additional debt to finance its acquisition of Rotech Healthcare Holdings. The ...

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments.

Notwithstanding the losses, the business highlighted strong success in its Patient Direct division, which witnessed consistent mid-single-digit growth. Over the previous year, Owens & Minor also ...

We are commencing a process to raise additional debt while the capital markets are attractive, to finance our previously announced agreement ...

Owens & Minor announced its $1.32 billion acquisition of Rotech in July 2024, paying 6.3x EBITDA. It sells home medical equipment, consistent with OMI’s aim of growing its patient-direct business.

Baird lowered the firm’s price target on Owens & Minor to $14 from $15 and keeps a Neutral rating on the shares. The firm said its preliminary Q4 results were disappointing. Published first on ...

Owens & Minor (OMI), which belongs to the Zacks Medical - Products industry, could be a great candidate to consider. When looking at the last two reports, this medical supply distributor has ...

In this article, we are going to take a look at where Owens & Minor, Inc. (NYSE:OMI) stands against the other rebound stocks. The United States economy is in a constant state of flux. In recent ...

The "FACE" singer graced New York Fashion Week in a pair of rock star boots from Rick Owen's apocalyptic fall 2023 menswear ...

Owens & Minor's President & Chief Executive Officer, Edward A. Pesicka, commented on the company's top-line performance in 2024 and the growth of the Patient Direct segment, as well as the ...

Shares of Owens & Minor touched a four-year low after the company said it took a $310 million goodwill impairment last quarter and would take on more debt to fund an acquisition. The stock fell 32 ...